GZF · Class II · 21 CFR 882.5870

FDA Product Code GZF: Stimulator, Peripheral Nerve, Implanted (pain Relief)

Leading manufacturers include Bioventus, LLC, Boston Scientific Neuromodulation and Curonix.

24
Total
24
Cleared
181d
Avg days
1991
Since
Growing category - 4 submissions in the last 2 years vs 1 in the prior period
Review times increasing: avg 270d recently vs 163d historically

FDA 510(k) Cleared Stimulator, Peripheral Nerve, Implanted (pain Relief) Devices (Product Code GZF)

24 devices
1–24 of 24

About Product Code GZF - Regulatory Context

510(k) Submission Activity

24 total 510(k) submissions under product code GZF since 1991, with 24 receiving FDA clearance (average review time: 181 days).

Submission volume has increased in recent years - 4 submissions in the last 24 months compared to 1 in the prior period - suggesting growing market activity in this device classification.

FDA Review Time

Recent submissions under GZF have taken an average of 270 days to reach a decision - up from 163 days historically. Manufacturers should account for longer review timelines in current project planning.

GZF devices are reviewed by the Neurology panel. Browse all Neurology devices →